Analyst Recommendation Trends
Wall Street analyst consensus for OPCH over the last few months:
Latest OPCH News
2 Profitable Stocks on Our Buy List and 1 We Find Risky
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
BTSG Deploys AI Across Operations: Will It Improve Margins?
BrightSpring Health Services is expanding AI and automation across its operations, with early margin gains and more benefits expected later in 2026 and 2027.
Option Care Health (OPCH) Draws Fresh Home Care Attention, Is It Still 20% Undervalued?
Option Care Health (OPCH) is back in focus after fresh commentary compared its home and alternate site infusion business with BrightSpring Health Services, highlighting how both could benefit as complex treatments continue shifting into lower cost home settings. Recent trading tells a mixed story. Option Care Health’s share price is up 8.41% over the past 90 days but down 29.25% year to date, while the 1 year total shareholder return has declined 17.83%, which may hint at fading momentum...
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BrightSpring vs. Option Care Health: Which Healthcare Stock Is Better?
BrightSpring's faster growth, pharmacy and provider-service expansion, and improving margins contrast with OPCH's slower growth and chronic-therapy pressures.
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Healthcare Stocks with Warning Signs
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 38.9% over the past six months, topping the S&P 500 by 20.9 percentage points.
3 Reasons to Sell OPCH and 1 Stock to Buy Instead
Over the last six months, Option Care Health’s shares have sunk to $23.95, producing a disappointing 15.7% loss - a stark contrast to the S&P 500’s 16.2% gain. This might have investors contemplating their next move.
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Option Care Health, Inc. (OPCH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Option Care Health, Inc. (OPCH) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 10:45 AM EDTCompany ParticipantsJohn Rademacher -...
BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?
BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.
2 Small-Cap Stocks with Promising Prospects and 1 We Brush Off
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Should Value Investors Buy Option Care Health (OPCH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.
Senior Health, Home Health & Hospice Stocks Q2 Results: Benchmarking Option Care Health (NASDAQ:OPCH)
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the senior health, home health & hospice stocks, including Option Care Health (NASDAQ:OPCH) and its peers.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-06 | Bhatia Prateek | +23,409 | - | - |
| 2026-07-06 | Bhatia Prateek | +16,386 | - | - |
| 2026-05-20 | Bierbower Elizabeth D | +8,997 | - | - |
| 2026-05-20 | Deckmann Natasha | +844 | $22.23 | $18,762 |
| 2026-05-20 | Deckmann Natasha | +8,997 | - | - |
| 2026-05-20 | KRAEMER HARRY M JANSEN JR | +12,079 | $22.23 | $268,516 |
| 2026-05-20 | KRAEMER HARRY M JANSEN JR | +8,997 | - | - |
| 2026-05-20 | Pate R Carter | +8,997 | - | - |
| 2026-05-20 | SULLIVAN TIMOTHY P | +4,836 | $22.23 | $107,504 |
| 2026-05-20 | SULLIVAN TIMOTHY P | +8,997 | - | - |
| 2026-05-20 | Bodem Barbara W. | +8,997 | - | - |
| 2026-05-20 | Wright Norman L. | +8,997 | - | - |
| 2026-05-20 | BRANDT ERIC | +2,643 | $22.23 | $58,754 |
| 2026-05-20 | BRANDT ERIC | +8,997 | - | - |
| 2026-05-19 | Smyser Collin | -812 | - | - |
| 2026-05-19 | Smyser Collin | -360 | $20.86 | $7,510 |
| 2026-05-19 | Smyser Collin | +812 | - | - |
| 2026-05-07 | SULLIVAN TIMOTHY P | +24,154 | $20.6869 | $499,671 |
| 2026-05-04 | KRAEMER HARRY M JANSEN JR | +36,610 | $21.4087 | $783,773 |
| 2026-05-04 | Sethna Meenal | +16,225 | $20.1587 | $327,075 |
| 2026-05-04 | RADEMACHER JOHN CHARLES | +12,500 | $21.1765 | $264,706 |
| 2026-04-22 | Adewunmi Femi | -1,396 | $28.38 | $39,618 |
| 2026-02-27 | Pate R Carter | -30,287 | $32.0474 | $970,620 |
| 2026-02-27 | Bavaro Michael | -6,000 | $33 | $198,000 |
| 2026-02-24 | Adewunmi Femi | -1,627 | $33.815 | $55,017 |
| 2026-02-24 | RADEMACHER JOHN CHARLES | -11,050 | $33.815 | $373,656 |
| 2026-02-24 | Bavaro Michael | -1,354 | $33.815 | $45,786 |
| 2026-02-24 | Maggio Nicole | -975 | $33.815 | $32,970 |
| 2026-02-24 | Whitworth Luke | -4,605 | $33.815 | $155,718 |
| 2026-02-24 | Grashoff Christopher L. | -1,980 | $33.815 | $66,954 |
| 2026-02-24 | Smyser Collin | -2,210 | $33.815 | $74,731 |
| 2026-02-22 | Bavaro Michael | -12,212 | $35.69 | $435,846 |
| 2026-02-22 | Grashoff Christopher L. | -538 | $35.69 | $19,201 |
| 2026-02-22 | Maggio Nicole | -372 | $35.69 | $13,277 |
| 2026-02-22 | Whitworth Luke | -24,029 | $35.69 | $857,595 |
| 2026-02-22 | RADEMACHER JOHN CHARLES | -132,848 | $35.69 | $4,741,345 |
| 2026-02-22 | Smyser Collin | -15,433 | $35.69 | $550,804 |
| 2026-02-21 | RADEMACHER JOHN CHARLES | -11,087 | - | - |
| 2026-02-21 | RADEMACHER JOHN CHARLES | -4,956 | $35.69 | $176,880 |
| 2026-02-21 | RADEMACHER JOHN CHARLES | +11,087 | - | - |
| 2026-02-20 | Bavaro Michael | -1,187 | $35.69 | $42,364 |
| 2026-02-20 | Grashoff Christopher L. | -1,948 | $35.69 | $69,524 |
| 2026-02-20 | Maggio Nicole | -619 | $35.69 | $22,092 |
| 2026-02-20 | Whitworth Luke | -4,015 | $35.69 | $143,295 |
| 2026-02-20 | RADEMACHER JOHN CHARLES | -10,638 | $35.69 | $379,670 |
| 2026-02-20 | Smyser Collin | -2,012 | $35.69 | $71,808 |
| 2026-02-18 | Whitworth Luke | +30,423 | - | - |
| 2026-02-18 | Grashoff Christopher L. | +12,678 | - | - |
| 2026-02-18 | Bavaro Michael | +9,579 | - | - |
| 2026-02-18 | Maggio Nicole | +4,226 | - | - |
| 2026-02-18 | RADEMACHER JOHN CHARLES | +78,876 | - | - |
| 2026-02-18 | Adewunmi Femi | +9,579 | - | - |
| 2026-02-18 | Sethna Meenal | +27,045 | - | - |
| 2026-02-18 | Smyser Collin | +15,213 | - | - |
| 2026-02-17 | Whitworth Luke | -508 | $35.24 | $17,902 |
| 2026-02-17 | Grashoff Christopher L. | -259 | $35.24 | $9,127 |
| 2026-02-17 | Bavaro Michael | -551 | $35.24 | $19,417 |
| 2026-02-17 | Maggio Nicole | -247 | $35.24 | $8,704 |
| 2025-11-03 | KRAEMER HARRY M JANSEN JR | +38,000 | $25.984 | $987,392 |